A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer
- PMID: 28916879
- DOI: 10.1007/s00259-017-3824-z
A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer
Abstract
Purpose: We investigated whether a score combining baseline neutrophilia and a PET biomarker could predict outcome in patients with locally advanced cervical cancer (LACC).
Methods: Patients homogeneously treated with definitive chemoradiation plus image-guided adaptive brachytherapy (IGABT) between 2006 and 2013 were analyzed retrospectively. We divided patients into two groups depending on the PET device used: a training set (TS) and a validation set (VS). Primary tumors were semi-automatically delineated on PET images, and 11 radiomics features were calculated (LIFEx software). A PET radiomic index was selected using the time-dependent area under the curve (td-AUC) for 3-year local control (LC). We defined the neutrophil SUV grade (NSG = 0, 1 or 2) score as the number of risk factors among (i) neutrophilia (neutrophil count >7 G/L) and (ii) high risk defined from the PET radiomic index. The NSG prognostic value was evaluated for LC and overall survival (OS).
Results: Data from 108 patients were analyzed. Estimated 3-year LC was 72% in the TS (n = 69) and 65% in the VS (n = 39). In the TS, SUVpeak was selected as the most LC-predictive biomarker (td-AUC = 0.75), and was independent from neutrophilia (p = 0.119). Neutrophilia (HR = 2.6), high-risk SUVpeak (SUVpeak > 10, HR = 4.4) and NSG = 2 (HR = 9.2) were associated with low probability of LC in TS. In multivariate analysis, NSG = 2 was independently associated with low probability of LC (HR = 7.5, p < 0.001) and OS (HR = 5.8, p = 0.001) in the TS. Results obtained in the VS (HR = 5.2 for OS and 3.5 for LC, p < 0.02) were promising.
Conclusion: This innovative scoring approach combining baseline neutrophilia and a PET biomarker provides an independent prognostic factor to consider for further clinical investigations.
Keywords: Biomarkers; Brachytherapy; Cervical carcinoma; Neutrophilia; Prognostic factor; Radiomics.
Similar articles
-
Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?Oncotarget. 2016 Nov 15;7(46):74886-74894. doi: 10.18632/oncotarget.12440. Oncotarget. 2016. PMID: 27713124 Free PMC article.
-
Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.Eur J Nucl Med Mol Imaging. 2018 May;45(5):768-786. doi: 10.1007/s00259-017-3898-7. Epub 2017 Dec 9. Eur J Nucl Med Mol Imaging. 2018. PMID: 29222685
-
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?J Nucl Med. 2024 Jun 3;65(6):962-970. doi: 10.2967/jnumed.123.267044. J Nucl Med. 2024. PMID: 38548352
-
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.Oncotarget. 2017 Jun 27;8(26):43169-43179. doi: 10.18632/oncotarget.17856. Oncotarget. 2017. PMID: 28574816 Free PMC article.
-
Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.J Appl Clin Med Phys. 2017 Nov;18(6):32-48. doi: 10.1002/acm2.12170. Epub 2017 Sep 11. J Appl Clin Med Phys. 2017. PMID: 28891217 Free PMC article.
Cited by
-
Evaluating Focal 18F-FDG Uptake in Thyroid Gland with Radiomics.Nucl Med Mol Imaging. 2020 Oct;54(5):241-248. doi: 10.1007/s13139-020-00659-2. Epub 2020 Jul 28. Nucl Med Mol Imaging. 2020. PMID: 33088353 Free PMC article.
-
Development and Validation of a Deep Learning Radiomics Model Predicting Lymph Node Status in Operable Cervical Cancer.Front Oncol. 2020 Apr 15;10:464. doi: 10.3389/fonc.2020.00464. eCollection 2020. Front Oncol. 2020. PMID: 32373511 Free PMC article.
-
Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment.Front Oncol. 2021 Jun 2;11:659313. doi: 10.3389/fonc.2021.659313. eCollection 2021. Front Oncol. 2021. PMID: 34150626 Free PMC article.
-
Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer.Front Med (Lausanne). 2022 Dec 2;9:1046551. doi: 10.3389/fmed.2022.1046551. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569127 Free PMC article.
-
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics.Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2656-2672. doi: 10.1007/s00259-019-04372-x. Epub 2019 Jun 18. Eur J Nucl Med Mol Imaging. 2019. PMID: 31214791 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical